Stock Forecast
As of Wed Nov 25 2020 22:20:36 GMT+0000 (Coordinated Universal Time) shares of IN InMed Pharmaceuticals Inc. 2.46 percentage change in price since the previous day's close. Around 5735 of 5221000 changed hand on the market. The Stock opened at 4.19 with high and low of 4.07 and 4.19 respectively. The price/earnings ratio is: - and earning per share is -2.03. The stock quoted a 52 week high and low of 3.95 and 14.19 respectively.
BOSTON (AI Forecast Terminal) Wed, Nov 25, '20 AI Forecast today took the forecast actions: In the context of stock price realization of IN InMed Pharmaceuticals Inc. is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+30) for IN InMed Pharmaceuticals Inc. as below:
IN InMed Pharmaceuticals Inc. Credit Rating Overview
We rerate IN InMed Pharmaceuticals Inc. because Incremental risk charge, comprehensive risk measure. We use econometric methods for period (n+30) simulate with Tri-tet Oscillators Factor. Reference code is: 4107. Beta DRL value REG 27 Rational Demand Factor LD 5208.0042. Shared facilities with captive finance entities. When an issuer has a shared revolving credit facility with a captive finance entity, for purposes of calculating the issuer's liquidity sources, we net outstanding commercial paper at the captive from the revolver's borrowing availability. In these cases, we generally use an estimate of peak CP borrowings at the captive to avoid potentially overstating sources available to the issuer over a 12- to 24-month period. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.
Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for IN InMed Pharmaceuticals Inc. as below:
Frequently Asked Questions
Q: What is IN InMed Pharmaceuticals Inc. stock symbol?A: IN InMed Pharmaceuticals Inc. stock referred as TSE:IN
Q: What is IN InMed Pharmaceuticals Inc. stock price?
A: On share of IN InMed Pharmaceuticals Inc. stock can currently be purchased for approximately 4.16
Q: Do analysts recommend investors buy shares of IN InMed Pharmaceuticals Inc. ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for IN InMed Pharmaceuticals Inc. at daily forecast section
Q: What is the earning per share of IN InMed Pharmaceuticals Inc. ?
A: The earning per share of IN InMed Pharmaceuticals Inc. is -2.03
Q: What is the market capitalization of IN InMed Pharmaceuticals Inc. ?
A: The market capitalization of IN InMed Pharmaceuticals Inc. is 21719359
